BRIEF published on 03/24/2026 at 16:06, 2 hours 47 minutes ago Northwest Biotherapeutics Gains Positive Outlook with Innovative Therapy Regulatory Approval Glioblastoma Treatment Northwest Biotherapeutics DCVax-L Therapy Oncology Innovations
BRIEF published on 03/24/2026 at 16:06, 2 hours 47 minutes ago Northwest Biotherapeutics affiche des perspectives positives grâce à une thérapie innovante Traitement Du Glioblastome Approbation Réglementaire Biothérapies Du Nord-Ouest Thérapie DCVax-L Innovations En Oncologie
PRESS RELEASE published on 03/24/2026 at 16:01, 2 hours 52 minutes ago Original-Research: Northwest Biotherapeutics Inc. (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research initiates coverage on Northwest Biotherapeutics Inc., with a Buy rating and USD 1.00 price target. Company is developing DCVax-L for glioblastoma First Berlin Equity Research BUY Rating Coverage Northwest Biotherapeutics Inc. DCVax-L
Published on 03/24/2026 at 13:30, 5 hours 24 minutes ago GGL Resources Corp. Announces Closing of Earn-In Agreement with Nelson Resources Limited on Its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/24/2026 at 13:30, 5 hours 24 minutes ago Innodata Announces Date of Annual Shareholder Meeting
Published on 03/24/2026 at 12:35, 6 hours 19 minutes ago Silver X Acquires the High-Grade Pampas Gold-Silver Project, Expanding its Precious Metal Asset Base in Peru
Published on 03/24/2026 at 12:33, 6 hours 21 minutes ago Mako Mining Completes Acquisition of Mt. Hamilton in Nevada
Published on 03/24/2026 at 12:30, 6 hours 24 minutes ago Orogen Reports Record 2025 Financial Performance and Positions for Continued Growth in 2026
Published on 03/24/2026 at 18:39, 14 minutes ago EQS-Adhoc: FORTEC Elektronik Aktiengesellschaft: Adjustment of the earnings forecast for the financial year 2025/2026
Published on 03/24/2026 at 18:00, 54 minutes ago Cham Swiss Properties places bond of CHF 100 million
Published on 03/24/2026 at 17:50, 1 hour 4 minutes ago Annual General Meeting of Bellevue Group AG – all proposals approved
Published on 03/24/2026 at 16:50, 2 hours 4 minutes ago LR Health & Beauty SE announces successful conclusion of the Written Procedure initiated on 6 March 2026 under the 2024/2028 Bonds and issuance of Super Senior Bonds
